Detalhe da pesquisa
1.
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.
Lancet
; 377(9784): 2181-92, 2011 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-21663949
2.
Fractures and bone health monitoring in boys with Duchenne muscular dystrophy managed within the Scottish Muscle Network.
Neuromuscul Disord
; 29(1): 59-66, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30473133
3.
The second United Kingdom Heart and Renal Protection (UK-HARP-II) Study: a randomized controlled study of the biochemical safety and efficacy of adding ezetimibe to simvastatin as initial therapy among patients with CKD.
Am J Kidney Dis
; 47(3): 385-95, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16490616
4.
First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.
Am J Kidney Dis
; 45(3): 473-84, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15754269
5.
Positive impact of Tai Chi Chuan participation on biopsychosocial quality of life compared to exercise and sedentary controls: a cross-sectional survey.
J Complement Integr Med
; 102013 May 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-23735480
6.
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.
Transplant Res
; 2(1): 7, 2013 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-23641902